Home / Companies / Praxis Precision Medicines, Inc. / 5 Jun 2024
Praxis Precision Medicines, Inc.: meeting of 5 Jun 2024
Votes reported on Form N-PX, item by item
124 Form N-PX filers reported votes at the Praxis Precision Medicines, Inc. meeting of 5 Jun 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 26.1% of reported votes for; 30 filers withheld from or voted against at least one nominee.
94 vote records from 37 filers. 28 of the 36 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
148 vote records from 124 filers. 77 of the 119 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
47 vote records from 37 filers. 0 of the 36 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
47 vote records from 37 filers. 35 of the 36 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | Abstain or withhold * | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | Abstain or withhold * | Against * | For |
| Dimensional | Abstain or withhold * | Against * | For |
| State Street and SPDR | No report | For | No report |
| American Century | Abstain or withhold * | Against * | For |
| Franklin Templeton | For | Against * | For |
| Invesco | Split or no vote | Against * | For |
| Equitable | Abstain or withhold * | Against * | For |
| Charles Schwab | For | Against * | For |
| John Hancock and Manulife | Abstain or withhold * | Against * | For |
| Goldman Sachs | No report | Against * | No report |
| PGIM and Prudential | No report | Against * | No report |
| Jackson National funds | Abstain or withhold * | Against * | For |
| Northern Trust and FlexShares | For | For | For |
| T. Rowe Price | Abstain or withhold * | Against * | For |
| Nationwide | Abstain or withhold * | Against * | For |
| Victory Capital | Abstain or withhold * | Against * | For |
| Guggenheim and Rydex | Abstain or withhold * | Against * | For |
| BNY Mellon | No report | For | No report |
| Principal | Abstain or withhold * | Against * | For |
| MassMutual | Split or no vote | Split or no vote | Split or no vote |
| Janus Henderson | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Praxis Precision Medicines, Inc. meeting?
124 Form N-PX filers reported votes at the meeting of 5 Jun 2024. On say-on-pay, 77 of 119 voted against management (64.7%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Praxis Precision Medicines, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Praxis Precision Medicines, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Praxis Precision Medicines, Inc. with a meeting date within three days of 5 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.